138 related articles for article (PubMed ID: 18088034)
1. [Immune recovery vitritis].
Dujić M; Jevtović D
Srp Arh Celok Lek; 2007; 135(9-10):513-5. PubMed ID: 18088034
[TBL] [Abstract][Full Text] [Related]
2. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
Retina; 2001; 21(1):1-9. PubMed ID: 11217922
[TBL] [Abstract][Full Text] [Related]
3. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome.
Karavellas MP; Lowder CY; Macdonald C; Avila CP; Freeman WR
Arch Ophthalmol; 1998 Feb; 116(2):169-75. PubMed ID: 9488268
[TBL] [Abstract][Full Text] [Related]
4. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
Karavellas MP; Plummer DJ; Macdonald JC; Torriani FJ; Shufelt CL; Azen SP; Freeman WR
J Infect Dis; 1999 Mar; 179(3):697-700. PubMed ID: 9952380
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
[TBL] [Abstract][Full Text] [Related]
6. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
Arevalo JF; Mendoza AJ; Ferretti Y
Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Whitcup SM
JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
[TBL] [Abstract][Full Text] [Related]
8. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
[TBL] [Abstract][Full Text] [Related]
9. Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis.
Canzano JC; Reed JB; Morse LS
Retina; 1998; 18(5):443-7. PubMed ID: 9801041
[TBL] [Abstract][Full Text] [Related]
10. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
[TBL] [Abstract][Full Text] [Related]
11. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
[TBL] [Abstract][Full Text] [Related]
12. Changing patterns of HIV related ocular disease.
Rauz S; Murray PI
Sex Transm Infect; 1999 Feb; 75(1):18-20. PubMed ID: 10448336
[TBL] [Abstract][Full Text] [Related]
13. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
14. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).
Roels P
Optometry; 2004 Oct; 75(10):624-8. PubMed ID: 15508863
[TBL] [Abstract][Full Text] [Related]
15. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
16. [Severe case of cytomegalovirus-associated immune reconstitution syndrome in AIDS].
Yashiro S; Takeda N; Uemura A; Nakamura Y; Kasagi A; Yoshida N; Kikuchi Y; Oka S
Nippon Ganka Gakkai Zasshi; 2011 Jan; 115(1):34-40. PubMed ID: 21348231
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus retinitis after immune reconstitution.
Crum NF; Blade KA
AIDS Read; 2005 Apr; 15(4):186-8. PubMed ID: 15844238
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.
Song MK; Schrier RD; Smith IL; Plummer DJ; Freeman WR
Retina; 2002 Jun; 22(3):262-7. PubMed ID: 12055457
[TBL] [Abstract][Full Text] [Related]
20. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.
Deayton JR; Wilson P; Sabin CA; Davey CC; Johnson MA; Emery VC; Griffiths PD
AIDS; 2000 Jun; 14(9):1163-70. PubMed ID: 10894280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
